These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6808791)

  • 21. Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.
    Lai Z; Kimmel R; Petersen S; Thomas S; Pier G; Bezabeh B; Luo R; Schreiber JR
    Vaccine; 2005 May; 23(25):3264-71. PubMed ID: 15837231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Safety, reactogenicity and efficacy of pyoimmunogen in immunizing burn patients].
    Grishina IA; Panova IuM; Kolker II; Stanislavskii ES; Zarubina EK
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Jul; (7):34-7. PubMed ID: 6812327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Experimentally determined safety and immunological activity of vaccine based on antigens isolated from Pseudomonas aeruginosa in medium K-4].
    Nuriddinova NR; Sheremet'ev NN; Ivanova LE; Garib FIu; Iskhakova KhI
    Zh Mikrobiol Epidemiol Immunobiol; 2005; (3):57-60. PubMed ID: 16028515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Protective artificial polysaccharide-protein antigens made from the O-specific polysaccharides of Pseudomonas aeruginosa bacteria of the immunotypes 1, 2 and 7].
    Kul'shin VA; Antsiferova NG; Moroz AF; Dmitriev BA
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Nov; (11):69-71. PubMed ID: 2464262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection.
    Zaidi TS; Priebe GP; Pier GB
    Infect Immun; 2006 Feb; 74(2):975-83. PubMed ID: 16428743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective mechanism of the immune response to a ribosomal vaccine from Pseudomonas aeruginosa. I. In vivo protection studies in compromised animal models.
    Lieberman MM; Frank WJ
    J Surg Res; 1988 Mar; 44(3):242-50. PubMed ID: 3125388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Antigenic properties of Pseudomonas aeruginosa anatoxin and the protective action of antitoxic anti-Pseudomonas aeruginosa serum].
    Podgornaia LG; Dziuban NF
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Jun; (6):67-9. PubMed ID: 3092510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. X-ray Irradiated Vaccine Confers protection against Pneumonia caused by Pseudomonas aeruginosa.
    Li Y; Wang Z; Liu X; Tang J; Peng B; Wei Y
    Sci Rep; 2016 Feb; 6():18823. PubMed ID: 26879055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for antigenic differences among pyocins of Pseudomonas aeruginosa.
    Allen JC; Kelly PC
    Trans Am Clin Climatol Assoc; 1975; 86():51-8. PubMed ID: 52229
    [No Abstract]   [Full Text] [Related]  

  • 30. [Evaluation of the immunological activity of a vaccine from mutant Salmonella minnesota R 595 on a model of experimental Pseudomonas aeruginosa infection in mice].
    Likhoded VG; Apollonin AV; Gremiakova TA; Artemova EK
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Apr; (4):103-6. PubMed ID: 6408854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificity of the protective response induced by the slime layer of Pseudomonas aeruginosa.
    Mates A; Zand P
    J Hyg (Lond); 1974 Aug; 73(1):75-84. PubMed ID: 4213979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological evaluation of OMP-F of native Iranian Pseudomonas aeruginosa as a protective vaccine.
    Ahmadi H; Tabaraie B; Maleknia S; Pormirzagholi F; Nejati M; Hedayati MH
    J Infect Dev Ctries; 2012 Oct; 6(10):721-6. PubMed ID: 23103894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of a Protective Vaccine Against Lipopolysaccharide-Heterologous
    Liu C; Pan X; Xia B; Chen F; Jin Y; Bai F; Priebe G; Cheng Z; Jin S; Wu W
    Front Immunol; 2018; 9():1737. PubMed ID: 30093906
    [No Abstract]   [Full Text] [Related]  

  • 34. Protection against fatal Pseudomonas aeruginosa sepsis by immunization with smooth and rough lipopolysaccharides.
    Cryz SJ; Meadow PM; Fürer E; Germanier R
    Eur J Clin Microbiol; 1985 Apr; 4(2):180-5. PubMed ID: 3924605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
    Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigenic heterogeneity among pyocins of Pseudomonas aeruginosa.
    Allen JC; Kelly PC
    Infect Immun; 1975 Aug; 12(2):318-23. PubMed ID: 51006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice.
    Moriyama K; Wiener-Kronish JP; Sawa T
    Microbiol Immunol; 2009 Nov; 53(11):587-94. PubMed ID: 19903258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pseudomonas aeruginosa vaccine on the basis of antigens isolated from the supernatant of culture media K-4].
    Nuriddinova NR; Ivanova LE; Sheremet'ev NN; Garib FIu
    Zh Mikrobiol Epidemiol Immunobiol; 2002; (4):40-3. PubMed ID: 12449697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The protective properties of the lysosomal form of Pseudomonas aeruginosa anatoxin in a test of its active protection of experimental animals].
    Minukhin VV; Brodinova NS; Mikhaĭlova NA; Ivanova NN; Tsyganenko AIa; Vasil'chenko VN
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (4):69-72. PubMed ID: 8067120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective activity of immune sera against extracellular slime from Pseudomonas aeruginosa on experimental infection in mice.
    Sokalska M; Maresz-Babczyszyn J
    Arch Immunol Ther Exp (Warsz); 1981; 29(5):643-52. PubMed ID: 6812542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.